Genetic and clinical heterogeneity of ferroportin disease

Laura Cemonesi, Gian Luca Forni, Nadia Soriani, Martina Lamagna, Isabella Fermo, Filomena Daraio, Anna Galli, Daniela Pietra, Luca Malcovati, Maurizio Ferrari, Clara Camaschella, Mario Cazzola

Research output: Contribution to journalArticlepeer-review


Ferroportin is encoded by the SLC40A1 gene and mediates iron export from cells by interacting with hepcidin. SLC40A1 gene mutations are associated with an autosomal type of genetic iron overload described as haemochromatosis type 4, or HFE4 (Online Mendelian Inheritance in Man number 606069), or ferroportin disease. We report three families with this condition caused by novel SLC40A1 mutations. Denaturing high-performance liquid chromatography was employed to scan for the SLC40A1 gene. A D181V (A846T) mutation in exon 6 of the ferroportin gene was detected in the affected members of an Italian family and shown to have a de novo origin in a maternal germinal line. This mutation was associated with both parenchymal and reticuloendothelial iron overload in the liver, and with reduced urinary hepcidin excretion. A G80V (G543T) mutation in exon 3 was found in the affected members of an Italian family with autosomal hyperferritinaemia,. Finally, a G267D (G1104A) mutation was identified in exon 7 in a family of Chinese descent whose members presented with isolated hyperferritinaemia. Ferroportin disease represents a protean genetic condition in which the different SLC40A1 mutations appear to be responsible for phenotypic variability. This condition should be considered not only in families with autosomal iron overload or hyperferritinaemia, but also in cases of unexplained hyperferritinaemia.

Original languageEnglish
Pages (from-to)663-670
Number of pages8
JournalBritish Journal of Haematology
Issue number5
Publication statusPublished - Dec 2005


  • Ferritin
  • Ferroportin
  • Hepcidin
  • Iron
  • SLC40A1

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Genetic and clinical heterogeneity of ferroportin disease'. Together they form a unique fingerprint.

Cite this